Cannabinoids MarketSize, Share & Industry Analysis, 2026-2034By Cannabinoid TypeBy SourceBy Product FormBy Extraction MethodBy ApplicationBy Spectrum ProfileBy Purity GradeBy Route of AdministrationBy Distribution ChannelBy Legal Status
Full title & scope — all 10 axes with their segments
Cannabinoids Market Size, Share & Industry Analysis, By Cannabinoid Type (Cannabidiol, Tetrahydrocannabinol, Cannabigerol, Cannabinol, Cannabichromene, Cannabidiolic Acid, Other Cannabinoids), By Source (Hemp-Derived, Marijuana-Derived, Synthetic, Semi-Synthetic), By Product Form (Isolate, Distillate, Crude Extract, Oils and Tinctures, Capsules and Softgels, Edibles, Topicals, Vapes and Inhalables), By Extraction Method (CO2 Extraction, Solvent Extraction, Solventless Extraction, Chemical Synthesis and Biosynthesis), By Application (Pharmaceuticals, Nutraceuticals and Dietary Supplements, Food and Beverages, Cosmetics and Personal Care, Recreational and Adult Use, Pet and Veterinary Products, Research and Others), By Spectrum Profile (Full-Spectrum, Broad-Spectrum, Isolate), By Purity Grade (Pharmaceutical Grade, Food and Nutraceutical Grade, Cosmetic Grade, Industrial and Research Grade), By Route of Administration (Oral, Topical and Transdermal, Inhalation, Oromucosal Spray, Others), By Distribution Channel (Pharmacies and Drug Stores, Licensed Dispensaries, Online and E-commerce, Specialty and Health Stores, Business-to-Business Bulk Supply), By Legal Status (Prescription, Medical Cannabis Programmes, Adult-Use Regulated, Hemp-Derived Consumer Wellness), and Regional Forecast, 2026-2034
Last Updated: Oct 28, 2026Format: PDFReport ID: CDI-248814
TOC
Full table of contents for the published report, chapter by chapter.
Full chapter-and-section structure of the report. Segment, region, and company breakdowns are listed as scope. The underlying figures are in the sample and full report.
Table of Contents+−
Chapter 1.Executive Summary
1.1Strategic Imperatives
1.2Definition
1.3Cannabinoids Comparison By Segments
Chapter 2.Premium Insights
2.1Top 3 Trends to Watch
2.2Top 3 Strategies Followed by Major Players
2.3Top 3 Predictions by Contrive Datum Insights
2.4Top Investment Pockets
2.4.1Market Attractiveness Analysis, By Cannabinoid Type
2.4.2Market Attractiveness Analysis, By Source
2.4.3Market Attractiveness Analysis, By Product Form
2.4.4Market Attractiveness Analysis, By Extraction Method
2.4.5Market Attractiveness Analysis, By Application
2.4.6Market Attractiveness Analysis, By Spectrum Profile
2.4.7Market Attractiveness Analysis, By Purity Grade
2.4.8Market Attractiveness Analysis, By Route of Administration
2.4.9Market Attractiveness Analysis, By Distribution Channel
2.4.10Market Attractiveness Analysis, By Legal Status
2.5Key Market Participants — Intensity Mapping
2.6Insights From Primary Respondents
Chapter 3.Market Definition
Chapter 4.Research Methodology
4.1Research Approach
4.1.1Research Programs / Design
4.1.2Market Size Estimation
4.2Data Sources
4.2.1Secondary Sources
4.2.1.1Preliminary Data Mining
4.2.2Primary Sources
4.2.2.1Statistical Model
4.2.2.2Data Triangulation
4.2.2.3Research Objective
4.3Flow Of Methodology
4.4Top-Down / Bottom-Up Approach
Chapter 5.Strategic Imperatives & Market Outlook
Chapter 6.Go-to-Market (GTM) Strategies
6.1Market Focus & Value Proposition
6.1.1Target Customers, Priority Markets, and Core Value Proposition
6.1.2Product Differentiation and Positioning Logic
6.2Commercial Model & Pricing Strategy
6.2.1Pricing Approach and Value Capture
6.2.2Contracting, Bundling, and Monetization Framework
6.3Channels, Sales & Partnerships
6.3.1Direct and Indirect Channel Strategy
6.3.2Sales Execution Model and Strategic Partnerships
6.4Marketing, Launch & Execution Roadmap
6.4.1Marketing and Demand Generation Approach
6.4.2Launch Sequencing and Rollout Plan
6.5Operational Readiness & Governance KPIs
6.5.1Supply Chain and Operational Preparedness
6.5.2Regulatory Considerations, Risks, and Performance Tracking
Chapter 7.Market Trends, Strategy & Dynamics
7.1Trends Overview
7.2Strategic Overview
7.3Market Drivers
7.4Market Restraints
7.5Market Opportunities
7.6Market Challenges
7.7Impact Analysis of Market Dynamics
Chapter 8.Porter's Five Forces
8.1Bargaining Power of Suppliers
8.2Bargaining Power of Buyers
8.3Threat of New Entrants
8.4Threat of Substitutes
8.5Competitive Rivalry
Chapter 9.PESTEL Analysis
9.1Political
9.2Economic
9.3Social
9.4Technological
9.5Environmental
9.6Legal
Chapter 10.Value Chain Analysis
Chapter 11.Supply Chain Analysis
Chapter 12.Macro-Economic Factors
12.1Macro-Economic Factors Overview
12.2Forecast Factors — Relevance and Impact
Chapter 13.Market Cost Analysis
13.1Key Raw Materials Analysis
13.1.1Key Raw Materials
13.1.2Price Trend of Key Raw Materials
13.1.3Key Suppliers of Raw Materials
13.1.4Market Concentration Rate of Raw Materials
13.1.5Raw Materials
13.1.6Labor Cost
Chapter 14.Market Supply-Side Analysis
14.1Raw Materials
14.2Price Trends
14.3Industry Chain
14.4Raw Materials Sourcing
14.5Raw Materials Sources of Major Manufacturers
14.6Downstream Buyers
Chapter 15.Global Cannabinoids Market Size & Projections, 2020–2034, Revenue (USD Billion)
15.1Global Cannabinoids Market Size — Total
15.2Market Size, by Segment (By Cannabinoid Type, By Source, By Product Form, By Extraction Method, By Application, By Spectrum Profile, By Purity Grade, By Route of Administration, By Distribution Channel, By Legal Status)
Chapter 16.Global Cannabinoids Market Overview, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
16.1Introduction
16.2Global Cannabinoids Market Size, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
16.3Global Cannabinoids Market Share, By Cannabinoid Type (%)
16.3.1Cannabidiol (CBD)
16.3.1.1Market Size, By Cannabidiol (CBD), 2020–2034, Revenue (USD Billion)
16.3.1.2Cannabidiol (CBD) Size and Projections, By Source, 2020–2034, Revenue (USD Billion)
16.3.1.3Cannabidiol (CBD) Size and Projections, By Product Form, 2020–2034, Revenue (USD Billion)
16.3.1.4Cannabidiol (CBD) Size and Projections, By Extraction Method, 2020–2034, Revenue (USD Billion)
16.3.1.5Cannabidiol (CBD) Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
16.3.1.6Cannabidiol (CBD) Size and Projections, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
16.3.1.7Cannabidiol (CBD) Size and Projections, By Purity Grade, 2020–2034, Revenue (USD Billion)
16.3.1.8Cannabidiol (CBD) Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
16.3.1.9Cannabidiol (CBD) Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
16.3.1.10Cannabidiol (CBD) Size and Projections, By Legal Status, 2020–2034, Revenue (USD Billion)
16.3.2Tetrahydrocannabinol (THC)
16.3.3Cannabigerol (CBG)
16.3.4Cannabinol (CBN)
16.3.5Cannabichromene (CBC)
16.3.6Cannabidiolic Acid (CBDA)
16.3.7Other Cannabinoids
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 16.3.1 (Cannabidiol (CBD)).
Chapter 17.Global Cannabinoids Market Overview, By Source, 2020–2034, Revenue (USD Billion)
17.1Introduction
17.2Global Cannabinoids Market Size, By Source, 2020–2034, Revenue (USD Billion)
17.3Global Cannabinoids Market Share, By Source (%)
17.3.1Hemp-Derived
17.3.1.1Market Size, By Hemp-Derived, 2020–2034, Revenue (USD Billion)
17.3.1.2Hemp-Derived Size and Projections, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
17.3.1.3Hemp-Derived Size and Projections, By Product Form, 2020–2034, Revenue (USD Billion)
17.3.1.4Hemp-Derived Size and Projections, By Extraction Method, 2020–2034, Revenue (USD Billion)
17.3.1.5Hemp-Derived Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
17.3.1.6Hemp-Derived Size and Projections, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
17.3.1.7Hemp-Derived Size and Projections, By Purity Grade, 2020–2034, Revenue (USD Billion)
17.3.1.8Hemp-Derived Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
17.3.1.9Hemp-Derived Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
17.3.1.10Hemp-Derived Size and Projections, By Legal Status, 2020–2034, Revenue (USD Billion)
17.3.2Marijuana-Derived
17.3.3Synthetic
17.3.4Semi-Synthetic (Converted)
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 17.3.1 (Hemp-Derived).
Chapter 18.Global Cannabinoids Market Overview, By Product Form, 2020–2034, Revenue (USD Billion)
18.1Introduction
18.2Global Cannabinoids Market Size, By Product Form, 2020–2034, Revenue (USD Billion)
18.3Global Cannabinoids Market Share, By Product Form (%)
18.3.1Isolate
18.3.1.1Market Size, By Isolate, 2020–2034, Revenue (USD Billion)
18.3.1.2Isolate Size and Projections, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
18.3.1.3Isolate Size and Projections, By Source, 2020–2034, Revenue (USD Billion)
18.3.1.4Isolate Size and Projections, By Extraction Method, 2020–2034, Revenue (USD Billion)
18.3.1.5Isolate Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
18.3.1.6Isolate Size and Projections, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
18.3.1.7Isolate Size and Projections, By Purity Grade, 2020–2034, Revenue (USD Billion)
18.3.1.8Isolate Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
18.3.1.9Isolate Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
18.3.1.10Isolate Size and Projections, By Legal Status, 2020–2034, Revenue (USD Billion)
18.3.2Distillate
18.3.3Crude Extract
18.3.4Oils and Tinctures
18.3.5Capsules and Softgels
18.3.6Edibles
18.3.7Topicals
18.3.8Vapes and Inhalables
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 18.3.1 (Isolate).
Chapter 19.Global Cannabinoids Market Overview, By Extraction Method, 2020–2034, Revenue (USD Billion)
19.1Introduction
19.2Global Cannabinoids Market Size, By Extraction Method, 2020–2034, Revenue (USD Billion)
19.3Global Cannabinoids Market Share, By Extraction Method (%)
19.3.1CO2 Extraction
19.3.1.1Market Size, By CO2 Extraction, 2020–2034, Revenue (USD Billion)
19.3.1.2CO2 Extraction Size and Projections, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
19.3.1.3CO2 Extraction Size and Projections, By Source, 2020–2034, Revenue (USD Billion)
19.3.1.4CO2 Extraction Size and Projections, By Product Form, 2020–2034, Revenue (USD Billion)
19.3.1.5CO2 Extraction Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
19.3.1.6CO2 Extraction Size and Projections, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
19.3.1.7CO2 Extraction Size and Projections, By Purity Grade, 2020–2034, Revenue (USD Billion)
19.3.1.8CO2 Extraction Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
19.3.1.9CO2 Extraction Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
19.3.1.10CO2 Extraction Size and Projections, By Legal Status, 2020–2034, Revenue (USD Billion)
19.3.2Solvent Extraction
19.3.3Solventless Extraction
19.3.4Chemical Synthesis and Biosynthesis
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 19.3.1 (CO2 Extraction).
Chapter 20.Global Cannabinoids Market Overview, By Application, 2020–2034, Revenue (USD Billion)
20.1Introduction
20.2Global Cannabinoids Market Size, By Application, 2020–2034, Revenue (USD Billion)
20.3Global Cannabinoids Market Share, By Application (%)
20.3.1Pharmaceuticals
20.3.1.1Market Size, By Pharmaceuticals, 2020–2034, Revenue (USD Billion)
20.3.1.2Pharmaceuticals Size and Projections, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
20.3.1.3Pharmaceuticals Size and Projections, By Source, 2020–2034, Revenue (USD Billion)
20.3.1.4Pharmaceuticals Size and Projections, By Product Form, 2020–2034, Revenue (USD Billion)
20.3.1.5Pharmaceuticals Size and Projections, By Extraction Method, 2020–2034, Revenue (USD Billion)
20.3.1.6Pharmaceuticals Size and Projections, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
20.3.1.7Pharmaceuticals Size and Projections, By Purity Grade, 2020–2034, Revenue (USD Billion)
20.3.1.8Pharmaceuticals Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
20.3.1.9Pharmaceuticals Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
20.3.1.10Pharmaceuticals Size and Projections, By Legal Status, 2020–2034, Revenue (USD Billion)
20.3.2Nutraceuticals and Dietary Supplements
20.3.3Food and Beverages
20.3.4Cosmetics and Personal Care
20.3.5Recreational and Adult Use
20.3.6Pet and Veterinary Products
20.3.7Research and Others
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 20.3.1 (Pharmaceuticals).
Chapter 21.Global Cannabinoids Market Overview, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
21.1Introduction
21.2Global Cannabinoids Market Size, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
21.3Global Cannabinoids Market Share, By Spectrum Profile (%)
21.3.1Full-Spectrum
21.3.1.1Market Size, By Full-Spectrum, 2020–2034, Revenue (USD Billion)
21.3.1.2Full-Spectrum Size and Projections, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
21.3.1.3Full-Spectrum Size and Projections, By Source, 2020–2034, Revenue (USD Billion)
21.3.1.4Full-Spectrum Size and Projections, By Product Form, 2020–2034, Revenue (USD Billion)
21.3.1.5Full-Spectrum Size and Projections, By Extraction Method, 2020–2034, Revenue (USD Billion)
21.3.1.6Full-Spectrum Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
21.3.1.7Full-Spectrum Size and Projections, By Purity Grade, 2020–2034, Revenue (USD Billion)
21.3.1.8Full-Spectrum Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
21.3.1.9Full-Spectrum Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
21.3.1.10Full-Spectrum Size and Projections, By Legal Status, 2020–2034, Revenue (USD Billion)
21.3.2Broad-Spectrum
21.3.3Isolate (Single Molecule)
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 21.3.1 (Full-Spectrum).
Chapter 22.Global Cannabinoids Market Overview, By Purity Grade, 2020–2034, Revenue (USD Billion)
22.1Introduction
22.2Global Cannabinoids Market Size, By Purity Grade, 2020–2034, Revenue (USD Billion)
22.3Global Cannabinoids Market Share, By Purity Grade (%)
22.3.1Pharmaceutical Grade
22.3.1.1Market Size, By Pharmaceutical Grade, 2020–2034, Revenue (USD Billion)
22.3.1.2Pharmaceutical Grade Size and Projections, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
22.3.1.3Pharmaceutical Grade Size and Projections, By Source, 2020–2034, Revenue (USD Billion)
22.3.1.4Pharmaceutical Grade Size and Projections, By Product Form, 2020–2034, Revenue (USD Billion)
22.3.1.5Pharmaceutical Grade Size and Projections, By Extraction Method, 2020–2034, Revenue (USD Billion)
22.3.1.6Pharmaceutical Grade Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
22.3.1.7Pharmaceutical Grade Size and Projections, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
22.3.1.8Pharmaceutical Grade Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
22.3.1.9Pharmaceutical Grade Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
22.3.1.10Pharmaceutical Grade Size and Projections, By Legal Status, 2020–2034, Revenue (USD Billion)
22.3.2Food and Nutraceutical Grade
22.3.3Cosmetic Grade
22.3.4Industrial and Research Grade
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 22.3.1 (Pharmaceutical Grade).
Chapter 23.Global Cannabinoids Market Overview, By Route of Administration, 2020–2034, Revenue (USD Billion)
23.1Introduction
23.2Global Cannabinoids Market Size, By Route of Administration, 2020–2034, Revenue (USD Billion)
23.3Global Cannabinoids Market Share, By Route of Administration (%)
23.3.1Oral
23.3.1.1Market Size, By Oral, 2020–2034, Revenue (USD Billion)
23.3.1.2Oral Size and Projections, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
23.3.1.3Oral Size and Projections, By Source, 2020–2034, Revenue (USD Billion)
23.3.1.4Oral Size and Projections, By Product Form, 2020–2034, Revenue (USD Billion)
23.3.1.5Oral Size and Projections, By Extraction Method, 2020–2034, Revenue (USD Billion)
23.3.1.6Oral Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
23.3.1.7Oral Size and Projections, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
23.3.1.8Oral Size and Projections, By Purity Grade, 2020–2034, Revenue (USD Billion)
23.3.1.9Oral Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
23.3.1.10Oral Size and Projections, By Legal Status, 2020–2034, Revenue (USD Billion)
23.3.2Topical and Transdermal
23.3.3Inhalation
23.3.4Oromucosal Spray
23.3.5Others
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 23.3.1 (Oral).
Chapter 24.Global Cannabinoids Market Overview, By Distribution Channel, 2020–2034, Revenue (USD Billion)
24.1Introduction
24.2Global Cannabinoids Market Size, By Distribution Channel, 2020–2034, Revenue (USD Billion)
24.3Global Cannabinoids Market Share, By Distribution Channel (%)
24.3.1Pharmacies and Drug Stores
24.3.1.1Market Size, By Pharmacies and Drug Stores, 2020–2034, Revenue (USD Billion)
24.3.1.2Pharmacies and Drug Stores Size and Projections, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
24.3.1.3Pharmacies and Drug Stores Size and Projections, By Source, 2020–2034, Revenue (USD Billion)
24.3.1.4Pharmacies and Drug Stores Size and Projections, By Product Form, 2020–2034, Revenue (USD Billion)
24.3.1.5Pharmacies and Drug Stores Size and Projections, By Extraction Method, 2020–2034, Revenue (USD Billion)
24.3.1.6Pharmacies and Drug Stores Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
24.3.1.7Pharmacies and Drug Stores Size and Projections, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
24.3.1.8Pharmacies and Drug Stores Size and Projections, By Purity Grade, 2020–2034, Revenue (USD Billion)
24.3.1.9Pharmacies and Drug Stores Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
24.3.1.10Pharmacies and Drug Stores Size and Projections, By Legal Status, 2020–2034, Revenue (USD Billion)
24.3.2Licensed Dispensaries
24.3.3Online and E-commerce
24.3.4Specialty and Health Stores
24.3.5Business-to-Business Bulk Supply
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 24.3.1 (Pharmacies and Drug Stores).
Chapter 25.Global Cannabinoids Market Overview, By Legal Status, 2020–2034, Revenue (USD Billion)
25.1Introduction
25.2Global Cannabinoids Market Size, By Legal Status, 2020–2034, Revenue (USD Billion)
25.3Global Cannabinoids Market Share, By Legal Status (%)
25.3.1Prescription (Approved Drugs)
25.3.1.1Market Size, By Prescription (Approved Drugs), 2020–2034, Revenue (USD Billion)
25.3.1.2Prescription (Approved Drugs) Size and Projections, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
25.3.1.3Prescription (Approved Drugs) Size and Projections, By Source, 2020–2034, Revenue (USD Billion)
25.3.1.4Prescription (Approved Drugs) Size and Projections, By Product Form, 2020–2034, Revenue (USD Billion)
25.3.1.5Prescription (Approved Drugs) Size and Projections, By Extraction Method, 2020–2034, Revenue (USD Billion)
25.3.1.6Prescription (Approved Drugs) Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
25.3.1.7Prescription (Approved Drugs) Size and Projections, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
25.3.1.8Prescription (Approved Drugs) Size and Projections, By Purity Grade, 2020–2034, Revenue (USD Billion)
25.3.1.9Prescription (Approved Drugs) Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
25.3.1.10Prescription (Approved Drugs) Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
25.3.2Medical Cannabis Programmes
25.3.3Adult-Use Regulated
25.3.4Hemp-Derived Consumer Wellness
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 25.3.1 (Prescription (Approved Drugs)).
Chapter 26.Global Cannabinoids Market Size — Segment Comparison
Chapter 27.Global Cannabinoids Geography Overview, 2020–2034, Revenue (USD Billion)
27.1Revenue, By Geography, 2020–2034, Revenue (USD Billion)
27.2Share, By Geography, 2020–2034 (%)
27.3Share, By Geography Analysis, 2025, Market Share and CAGR
27.4Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Chapter 28.North America Cannabinoids Market Deep-Dive, 2020–2034, Revenue (USD Billion)
28.1Overview, 2020–2034
28.2Size and Projections, 2020–2034, Revenue (USD Billion)
28.2.1By Cannabinoid Type, 2020–2034
28.2.2By Source, 2020–2034
28.2.3By Product Form, 2020–2034
28.2.4By Extraction Method, 2020–2034
28.2.5By Application, 2020–2034
28.2.6By Spectrum Profile, 2020–2034
28.2.7By Purity Grade, 2020–2034
28.2.8By Route of Administration, 2020–2034
28.2.9By Distribution Channel, 2020–2034
28.2.10By Legal Status, 2020–2034
28.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
28.3.1US
28.3.1.1US — Key Country Dynamics
28.3.1.2US — Regulatory Framework
28.3.1.3US — Competitive Scenario
28.3.1.4US — Market Overview, 2020–2034, Revenue (USD Billion)
28.3.1.5US — Market Size and Projections, 2020–2034, Revenue (USD Billion)
28.3.1.6US Market Overview, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
28.3.1.7US Market Overview, By Source, 2020–2034, Revenue (USD Billion)
28.3.1.8US Market Overview, By Product Form, 2020–2034, Revenue (USD Billion)
28.3.1.9US Market Overview, By Extraction Method, 2020–2034, Revenue (USD Billion)
28.3.1.10US Market Overview, By Application, 2020–2034, Revenue (USD Billion)
28.3.1.11US Market Overview, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
28.3.1.12US Market Overview, By Purity Grade, 2020–2034, Revenue (USD Billion)
28.3.1.13US Market Overview, By Route of Administration, 2020–2034, Revenue (USD Billion)
28.3.1.14US Market Overview, By Distribution Channel, 2020–2034, Revenue (USD Billion)
28.3.1.15US Market Overview, By Legal Status, 2020–2034, Revenue (USD Billion)
28.3.2Canada
28.3.3Mexico
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 28.3.1 (US).
Chapter 29.Europe Cannabinoids Market Deep-Dive, 2020–2034, Revenue (USD Billion)
29.1Overview, 2020–2034
29.2Size and Projections, 2020–2034, Revenue (USD Billion)
29.2.1By Cannabinoid Type, 2020–2034
29.2.2By Source, 2020–2034
29.2.3By Product Form, 2020–2034
29.2.4By Extraction Method, 2020–2034
29.2.5By Application, 2020–2034
29.2.6By Spectrum Profile, 2020–2034
29.2.7By Purity Grade, 2020–2034
29.2.8By Route of Administration, 2020–2034
29.2.9By Distribution Channel, 2020–2034
29.2.10By Legal Status, 2020–2034
29.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
29.3.1Germany
29.3.1.1Germany — Key Country Dynamics
29.3.1.2Germany — Regulatory Framework
29.3.1.3Germany — Competitive Scenario
29.3.1.4Germany — Market Overview, 2020–2034, Revenue (USD Billion)
29.3.1.5Germany — Market Size and Projections, 2020–2034, Revenue (USD Billion)
29.3.1.6Germany Market Overview, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
29.3.1.7Germany Market Overview, By Source, 2020–2034, Revenue (USD Billion)
29.3.1.8Germany Market Overview, By Product Form, 2020–2034, Revenue (USD Billion)
29.3.1.9Germany Market Overview, By Extraction Method, 2020–2034, Revenue (USD Billion)
29.3.1.10Germany Market Overview, By Application, 2020–2034, Revenue (USD Billion)
29.3.1.11Germany Market Overview, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
29.3.1.12Germany Market Overview, By Purity Grade, 2020–2034, Revenue (USD Billion)
29.3.1.13Germany Market Overview, By Route of Administration, 2020–2034, Revenue (USD Billion)
29.3.1.14Germany Market Overview, By Distribution Channel, 2020–2034, Revenue (USD Billion)
29.3.1.15Germany Market Overview, By Legal Status, 2020–2034, Revenue (USD Billion)
29.3.2France
29.3.3Italy
29.3.4Spain
29.3.5UK
29.3.6Nordic Countries
29.3.7Benelux Union
29.3.8Rest of Europe
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 29.3.1 (Germany).
Chapter 30.Asia Pacific Cannabinoids Market Deep-Dive, 2020–2034, Revenue (USD Billion)
30.1Overview, 2020–2034
30.2Size and Projections, 2020–2034, Revenue (USD Billion)
30.2.1By Cannabinoid Type, 2020–2034
30.2.2By Source, 2020–2034
30.2.3By Product Form, 2020–2034
30.2.4By Extraction Method, 2020–2034
30.2.5By Application, 2020–2034
30.2.6By Spectrum Profile, 2020–2034
30.2.7By Purity Grade, 2020–2034
30.2.8By Route of Administration, 2020–2034
30.2.9By Distribution Channel, 2020–2034
30.2.10By Legal Status, 2020–2034
30.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
30.3.1India
30.3.1.1India — Key Country Dynamics
30.3.1.2India — Regulatory Framework
30.3.1.3India — Competitive Scenario
30.3.1.4India — Market Overview, 2020–2034, Revenue (USD Billion)
30.3.1.5India — Market Size and Projections, 2020–2034, Revenue (USD Billion)
30.3.1.6India Market Overview, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
30.3.1.7India Market Overview, By Source, 2020–2034, Revenue (USD Billion)
30.3.1.8India Market Overview, By Product Form, 2020–2034, Revenue (USD Billion)
30.3.1.9India Market Overview, By Extraction Method, 2020–2034, Revenue (USD Billion)
30.3.1.10India Market Overview, By Application, 2020–2034, Revenue (USD Billion)
30.3.1.11India Market Overview, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
30.3.1.12India Market Overview, By Purity Grade, 2020–2034, Revenue (USD Billion)
30.3.1.13India Market Overview, By Route of Administration, 2020–2034, Revenue (USD Billion)
30.3.1.14India Market Overview, By Distribution Channel, 2020–2034, Revenue (USD Billion)
30.3.1.15India Market Overview, By Legal Status, 2020–2034, Revenue (USD Billion)
30.3.2Australia
30.3.3China
30.3.4China (Taiwan)
30.3.5Japan
30.3.6South Korea
30.3.7Southeast Asia
30.3.8Indonesia
30.3.9Thailand
30.3.10Malaysia
30.3.11Singapore
30.3.12Rest of Asia Pacific
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 30.3.1 (India).
Chapter 31.Latin America Cannabinoids Market Deep-Dive, 2020–2034, Revenue (USD Billion)
31.1Overview, 2020–2034
31.2Size and Projections, 2020–2034, Revenue (USD Billion)
31.2.1By Cannabinoid Type, 2020–2034
31.2.2By Source, 2020–2034
31.2.3By Product Form, 2020–2034
31.2.4By Extraction Method, 2020–2034
31.2.5By Application, 2020–2034
31.2.6By Spectrum Profile, 2020–2034
31.2.7By Purity Grade, 2020–2034
31.2.8By Route of Administration, 2020–2034
31.2.9By Distribution Channel, 2020–2034
31.2.10By Legal Status, 2020–2034
31.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
31.3.1Brazil
31.3.1.1Brazil — Key Country Dynamics
31.3.1.2Brazil — Regulatory Framework
31.3.1.3Brazil — Competitive Scenario
31.3.1.4Brazil — Market Overview, 2020–2034, Revenue (USD Billion)
31.3.1.5Brazil — Market Size and Projections, 2020–2034, Revenue (USD Billion)
31.3.1.6Brazil Market Overview, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
31.3.1.7Brazil Market Overview, By Source, 2020–2034, Revenue (USD Billion)
31.3.1.8Brazil Market Overview, By Product Form, 2020–2034, Revenue (USD Billion)
31.3.1.9Brazil Market Overview, By Extraction Method, 2020–2034, Revenue (USD Billion)
31.3.1.10Brazil Market Overview, By Application, 2020–2034, Revenue (USD Billion)
31.3.1.11Brazil Market Overview, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
31.3.1.12Brazil Market Overview, By Purity Grade, 2020–2034, Revenue (USD Billion)
31.3.1.13Brazil Market Overview, By Route of Administration, 2020–2034, Revenue (USD Billion)
31.3.1.14Brazil Market Overview, By Distribution Channel, 2020–2034, Revenue (USD Billion)
31.3.1.15Brazil Market Overview, By Legal Status, 2020–2034, Revenue (USD Billion)
31.3.2Argentina
31.3.3Rest of Latin America
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 31.3.1 (Brazil).
Chapter 32.Middle East and Africa Cannabinoids Market Deep-Dive, 2020–2034, Revenue (USD Billion)
32.1Overview, 2020–2034
32.2Size and Projections, 2020–2034, Revenue (USD Billion)
32.2.1By Cannabinoid Type, 2020–2034
32.2.2By Source, 2020–2034
32.2.3By Product Form, 2020–2034
32.2.4By Extraction Method, 2020–2034
32.2.5By Application, 2020–2034
32.2.6By Spectrum Profile, 2020–2034
32.2.7By Purity Grade, 2020–2034
32.2.8By Route of Administration, 2020–2034
32.2.9By Distribution Channel, 2020–2034
32.2.10By Legal Status, 2020–2034
32.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
32.3.1GCC
32.3.1.1GCC — Key Country Dynamics
32.3.1.2GCC — Regulatory Framework
32.3.1.3GCC — Competitive Scenario
32.3.1.4GCC — Market Overview, 2020–2034, Revenue (USD Billion)
32.3.1.5GCC — Market Size and Projections, 2020–2034, Revenue (USD Billion)
32.3.1.6GCC Market Overview, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
32.3.1.7GCC Market Overview, By Source, 2020–2034, Revenue (USD Billion)
32.3.1.8GCC Market Overview, By Product Form, 2020–2034, Revenue (USD Billion)
32.3.1.9GCC Market Overview, By Extraction Method, 2020–2034, Revenue (USD Billion)
32.3.1.10GCC Market Overview, By Application, 2020–2034, Revenue (USD Billion)
32.3.1.11GCC Market Overview, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
32.3.1.12GCC Market Overview, By Purity Grade, 2020–2034, Revenue (USD Billion)
32.3.1.13GCC Market Overview, By Route of Administration, 2020–2034, Revenue (USD Billion)
32.3.1.14GCC Market Overview, By Distribution Channel, 2020–2034, Revenue (USD Billion)
32.3.1.15GCC Market Overview, By Legal Status, 2020–2034, Revenue (USD Billion)
32.3.2Egypt
32.3.3South Africa
32.3.4Rest of the Middle East & Africa
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 32.3.1 (GCC).
Chapter 33.Application / Use-Case Analysis
Chapter 34.Vendor Capability Scorecard
Chapter 35.Scenario Forecasts
35.1Bull-case Trajectory
35.2Base-case Trajectory
35.3Bear-case Trajectory
Chapter 36.Top 10 Key Clients of Top 10 Players
Chapter 37.Top 10 Suppliers
Chapter 38.Competitive Landscape
38.1Jazz Pharmaceuticals plc
38.2Canopy Growth Corporation
38.3Tilray Brands, Inc.
38.4Charlotte's Web Holdings, Inc.
38.5Aurora Cannabis Inc.
38.6Curaleaf Holdings, Inc.
38.7Cresco Labs Inc.
38.8Green Thumb Industries Inc.
38.9Trulieve Cannabis Corp.
38.10Mile High Labs, Inc.
38.11Medterra CBD
38.12cbdMD, Inc.
38.13Isodiol International Inc.
38.14Elixinol Wellness Limited
38.15Folium Biosciences
38.16Cannexus Group
38.17Cannextra
38.18Red Mesa Science & Refining
38.19Big Sky Scientific
38.20Avient Biosciences
38.21Organigram Global Inc.
38.22SNDL Inc.
38.23Bausch Health Companies Inc.
38.24Neuraxpharm Group
38.25Botanix Pharmaceuticals Limited
38.26Zynerba Pharmaceuticals, Inc.
38.27Aphria Inc.
38.28CV Sciences, Inc.
38.29Endoca
38.30Cronos Group Inc.
Chapter 39.Partnerships & M&A
Chapter 40.Key Vendor Analysis
40.1Jazz Pharmaceuticals plc
40.2Canopy Growth Corporation
40.3Tilray Brands, Inc.
40.4Charlotte's Web Holdings, Inc.
40.5Aurora Cannabis Inc.
40.6Curaleaf Holdings, Inc.
40.7Cresco Labs Inc.
40.8Green Thumb Industries Inc.
40.9Trulieve Cannabis Corp.
40.10Mile High Labs, Inc.
40.11Medterra CBD
40.12cbdMD, Inc.
40.13Isodiol International Inc.
40.14Elixinol Wellness Limited
40.15Folium Biosciences
40.16Cannexus Group
40.17Cannextra
40.18Red Mesa Science & Refining
40.19Big Sky Scientific
40.20Avient Biosciences
40.21Organigram Global Inc.
40.22SNDL Inc.
40.23Bausch Health Companies Inc.
40.24Neuraxpharm Group
40.25Botanix Pharmaceuticals Limited
40.26Zynerba Pharmaceuticals, Inc.
40.27Aphria Inc.
40.28CV Sciences, Inc.
40.29Endoca
40.30Cronos Group Inc.
Chapter 41.Marketing Strategy Analysis, Distributors & Traders
Chapter 42.Outlook of the Market
Chapter 43.Concluding Analyst Note
List of Figures+−
Structural index generated from this report's own section headings, not verified against the delivered report's actual figure numbering.
Figure 2.1Top 3 Trends to Watch
Figure 2.4Top Investment Pockets
Figure 2.4.1Market Attractiveness Analysis, By Cannabinoid Type
Figure 2.4.2Market Attractiveness Analysis, By Source
Figure 2.4.3Market Attractiveness Analysis, By Product Form
Figure 2.4.4Market Attractiveness Analysis, By Extraction Method
Figure 2.4.5Market Attractiveness Analysis, By Application
Figure 2.4.6Market Attractiveness Analysis, By Spectrum Profile
Figure 2.4.7Market Attractiveness Analysis, By Purity Grade
Figure 2.4.8Market Attractiveness Analysis, By Route of Administration
Figure 2.4.9Market Attractiveness Analysis, By Distribution Channel
Figure 2.4.10Market Attractiveness Analysis, By Legal Status
Figure 2.5Key Market Participants — Intensity Mapping
Figure 4.2.2.2Data Triangulation
Figure 4.3Flow Of Methodology
Figure 4.4Top-Down / Bottom-Up Approach
Figure 6.1.2Product Differentiation and Positioning Logic
Figure 16.3Global Cannabinoids Market Share, By Cannabinoid Type (%)
Figure 17.3Global Cannabinoids Market Share, By Source (%)
Figure 18.3Global Cannabinoids Market Share, By Product Form (%)
Figure 19.3Global Cannabinoids Market Share, By Extraction Method (%)
Figure 20.3Global Cannabinoids Market Share, By Application (%)
Figure 21.3Global Cannabinoids Market Share, By Spectrum Profile (%)
Figure 22.3Global Cannabinoids Market Share, By Purity Grade (%)
Figure 23.3Global Cannabinoids Market Share, By Route of Administration (%)
Figure 24.3Global Cannabinoids Market Share, By Distribution Channel (%)
Figure 25.3Global Cannabinoids Market Share, By Legal Status (%)
Figure 27.2Share, By Geography, 2020–2034 (%)
Figure 27.3Share, By Geography Analysis, 2025, Market Share and CAGR
List of Tables+−
Structural index generated from this report's own section headings, not verified against the delivered report's actual table numbering.
Table 1.3Cannabinoids Comparison By Segments
Table 4.1.2Market Size Estimation
Table 15.1Global Cannabinoids Market Size — Total
Table 15.2Market Size, by Segment (By Cannabinoid Type, By Source, By Product Form, By Extraction Method, By Application, By Spectrum Profile, By Purity Grade, By Route of Administration, By Distribution Channel, By Legal Status)
Table 16.2Global Cannabinoids Market Size, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
Table 16.3.1.1Market Size, By Cannabidiol (CBD), 2020–2034, Revenue (USD Billion)
Table 16.3.1.2Cannabidiol (CBD) Size and Projections, By Source, 2020–2034, Revenue (USD Billion)
Table 16.3.1.3Cannabidiol (CBD) Size and Projections, By Product Form, 2020–2034, Revenue (USD Billion)
Table 16.3.1.4Cannabidiol (CBD) Size and Projections, By Extraction Method, 2020–2034, Revenue (USD Billion)
Table 16.3.1.5Cannabidiol (CBD) Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 16.3.1.6Cannabidiol (CBD) Size and Projections, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
Table 16.3.1.7Cannabidiol (CBD) Size and Projections, By Purity Grade, 2020–2034, Revenue (USD Billion)
Table 16.3.1.8Cannabidiol (CBD) Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 16.3.1.9Cannabidiol (CBD) Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 16.3.1.10Cannabidiol (CBD) Size and Projections, By Legal Status, 2020–2034, Revenue (USD Billion)
Table 17.2Global Cannabinoids Market Size, By Source, 2020–2034, Revenue (USD Billion)
Table 17.3.1.1Market Size, By Hemp-Derived, 2020–2034, Revenue (USD Billion)
Table 17.3.1.2Hemp-Derived Size and Projections, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
Table 17.3.1.3Hemp-Derived Size and Projections, By Product Form, 2020–2034, Revenue (USD Billion)
Table 17.3.1.4Hemp-Derived Size and Projections, By Extraction Method, 2020–2034, Revenue (USD Billion)
Table 17.3.1.5Hemp-Derived Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 17.3.1.6Hemp-Derived Size and Projections, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
Table 17.3.1.7Hemp-Derived Size and Projections, By Purity Grade, 2020–2034, Revenue (USD Billion)
Table 17.3.1.8Hemp-Derived Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 17.3.1.9Hemp-Derived Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 17.3.1.10Hemp-Derived Size and Projections, By Legal Status, 2020–2034, Revenue (USD Billion)
Table 18.2Global Cannabinoids Market Size, By Product Form, 2020–2034, Revenue (USD Billion)
Table 18.3.1.1Market Size, By Isolate, 2020–2034, Revenue (USD Billion)
Table 18.3.1.2Isolate Size and Projections, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
Table 18.3.1.3Isolate Size and Projections, By Source, 2020–2034, Revenue (USD Billion)
Table 18.3.1.4Isolate Size and Projections, By Extraction Method, 2020–2034, Revenue (USD Billion)
Table 18.3.1.5Isolate Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 18.3.1.6Isolate Size and Projections, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
Table 18.3.1.7Isolate Size and Projections, By Purity Grade, 2020–2034, Revenue (USD Billion)
Table 18.3.1.8Isolate Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 18.3.1.9Isolate Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 18.3.1.10Isolate Size and Projections, By Legal Status, 2020–2034, Revenue (USD Billion)
Table 19.2Global Cannabinoids Market Size, By Extraction Method, 2020–2034, Revenue (USD Billion)
Table 19.3.1.1Market Size, By CO2 Extraction, 2020–2034, Revenue (USD Billion)
Table 19.3.1.2CO2 Extraction Size and Projections, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
Table 19.3.1.3CO2 Extraction Size and Projections, By Source, 2020–2034, Revenue (USD Billion)
Table 19.3.1.4CO2 Extraction Size and Projections, By Product Form, 2020–2034, Revenue (USD Billion)
Table 19.3.1.5CO2 Extraction Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 19.3.1.6CO2 Extraction Size and Projections, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
Table 19.3.1.7CO2 Extraction Size and Projections, By Purity Grade, 2020–2034, Revenue (USD Billion)
Table 19.3.1.8CO2 Extraction Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 19.3.1.9CO2 Extraction Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 19.3.1.10CO2 Extraction Size and Projections, By Legal Status, 2020–2034, Revenue (USD Billion)
Table 20.2Global Cannabinoids Market Size, By Application, 2020–2034, Revenue (USD Billion)
Table 20.3.1.1Market Size, By Pharmaceuticals, 2020–2034, Revenue (USD Billion)
Table 20.3.1.2Pharmaceuticals Size and Projections, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
Table 20.3.1.3Pharmaceuticals Size and Projections, By Source, 2020–2034, Revenue (USD Billion)
Table 20.3.1.4Pharmaceuticals Size and Projections, By Product Form, 2020–2034, Revenue (USD Billion)
Table 20.3.1.5Pharmaceuticals Size and Projections, By Extraction Method, 2020–2034, Revenue (USD Billion)
Table 20.3.1.6Pharmaceuticals Size and Projections, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
Table 20.3.1.7Pharmaceuticals Size and Projections, By Purity Grade, 2020–2034, Revenue (USD Billion)
Table 20.3.1.8Pharmaceuticals Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 20.3.1.9Pharmaceuticals Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 20.3.1.10Pharmaceuticals Size and Projections, By Legal Status, 2020–2034, Revenue (USD Billion)
Table 21.2Global Cannabinoids Market Size, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
Table 21.3.1.1Market Size, By Full-Spectrum, 2020–2034, Revenue (USD Billion)
Table 21.3.1.2Full-Spectrum Size and Projections, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
Table 21.3.1.3Full-Spectrum Size and Projections, By Source, 2020–2034, Revenue (USD Billion)
Table 21.3.1.4Full-Spectrum Size and Projections, By Product Form, 2020–2034, Revenue (USD Billion)
Table 21.3.1.5Full-Spectrum Size and Projections, By Extraction Method, 2020–2034, Revenue (USD Billion)
Table 21.3.1.6Full-Spectrum Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 21.3.1.7Full-Spectrum Size and Projections, By Purity Grade, 2020–2034, Revenue (USD Billion)
Table 21.3.1.8Full-Spectrum Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 21.3.1.9Full-Spectrum Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 21.3.1.10Full-Spectrum Size and Projections, By Legal Status, 2020–2034, Revenue (USD Billion)
Table 22.2Global Cannabinoids Market Size, By Purity Grade, 2020–2034, Revenue (USD Billion)
Table 22.3.1.1Market Size, By Pharmaceutical Grade, 2020–2034, Revenue (USD Billion)
Table 22.3.1.2Pharmaceutical Grade Size and Projections, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
Table 22.3.1.3Pharmaceutical Grade Size and Projections, By Source, 2020–2034, Revenue (USD Billion)
Table 22.3.1.4Pharmaceutical Grade Size and Projections, By Product Form, 2020–2034, Revenue (USD Billion)
Table 22.3.1.5Pharmaceutical Grade Size and Projections, By Extraction Method, 2020–2034, Revenue (USD Billion)
Table 22.3.1.6Pharmaceutical Grade Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 22.3.1.7Pharmaceutical Grade Size and Projections, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
Table 22.3.1.8Pharmaceutical Grade Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 22.3.1.9Pharmaceutical Grade Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 22.3.1.10Pharmaceutical Grade Size and Projections, By Legal Status, 2020–2034, Revenue (USD Billion)
Table 23.2Global Cannabinoids Market Size, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 23.3.1.1Market Size, By Oral, 2020–2034, Revenue (USD Billion)
Table 23.3.1.2Oral Size and Projections, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
Table 23.3.1.3Oral Size and Projections, By Source, 2020–2034, Revenue (USD Billion)
Table 23.3.1.4Oral Size and Projections, By Product Form, 2020–2034, Revenue (USD Billion)
Table 23.3.1.5Oral Size and Projections, By Extraction Method, 2020–2034, Revenue (USD Billion)
Table 23.3.1.6Oral Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 23.3.1.7Oral Size and Projections, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
Table 23.3.1.8Oral Size and Projections, By Purity Grade, 2020–2034, Revenue (USD Billion)
Table 23.3.1.9Oral Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 23.3.1.10Oral Size and Projections, By Legal Status, 2020–2034, Revenue (USD Billion)
Table 24.2Global Cannabinoids Market Size, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 24.3.1.1Market Size, By Pharmacies and Drug Stores, 2020–2034, Revenue (USD Billion)
Table 24.3.1.2Pharmacies and Drug Stores Size and Projections, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
Table 24.3.1.3Pharmacies and Drug Stores Size and Projections, By Source, 2020–2034, Revenue (USD Billion)
Table 24.3.1.4Pharmacies and Drug Stores Size and Projections, By Product Form, 2020–2034, Revenue (USD Billion)
Table 24.3.1.5Pharmacies and Drug Stores Size and Projections, By Extraction Method, 2020–2034, Revenue (USD Billion)
Table 24.3.1.6Pharmacies and Drug Stores Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 24.3.1.7Pharmacies and Drug Stores Size and Projections, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
Table 24.3.1.8Pharmacies and Drug Stores Size and Projections, By Purity Grade, 2020–2034, Revenue (USD Billion)
Table 24.3.1.9Pharmacies and Drug Stores Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 24.3.1.10Pharmacies and Drug Stores Size and Projections, By Legal Status, 2020–2034, Revenue (USD Billion)
Table 25.2Global Cannabinoids Market Size, By Legal Status, 2020–2034, Revenue (USD Billion)
Table 25.3.1.1Market Size, By Prescription (Approved Drugs), 2020–2034, Revenue (USD Billion)
Table 25.3.1.2Prescription (Approved Drugs) Size and Projections, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
Table 25.3.1.3Prescription (Approved Drugs) Size and Projections, By Source, 2020–2034, Revenue (USD Billion)
Table 25.3.1.4Prescription (Approved Drugs) Size and Projections, By Product Form, 2020–2034, Revenue (USD Billion)
Table 25.3.1.5Prescription (Approved Drugs) Size and Projections, By Extraction Method, 2020–2034, Revenue (USD Billion)
Table 25.3.1.6Prescription (Approved Drugs) Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 25.3.1.7Prescription (Approved Drugs) Size and Projections, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
Table 25.3.1.8Prescription (Approved Drugs) Size and Projections, By Purity Grade, 2020–2034, Revenue (USD Billion)
Table 25.3.1.9Prescription (Approved Drugs) Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 25.3.1.10Prescription (Approved Drugs) Size and Projections, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 27.1Revenue, By Geography, 2020–2034, Revenue (USD Billion)
Table 27.4Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 28.1Overview, 2020–2034
Table 28.2Size and Projections, 2020–2034, Revenue (USD Billion)
Table 28.2.1By Cannabinoid Type, 2020–2034
Table 28.2.2By Source, 2020–2034
Table 28.2.3By Product Form, 2020–2034
Table 28.2.4By Extraction Method, 2020–2034
Table 28.2.5By Application, 2020–2034
Table 28.2.6By Spectrum Profile, 2020–2034
Table 28.2.7By Purity Grade, 2020–2034
Table 28.2.8By Route of Administration, 2020–2034
Table 28.2.9By Distribution Channel, 2020–2034
Table 28.2.10By Legal Status, 2020–2034
Table 28.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 28.3.1.4US — Market Overview, 2020–2034, Revenue (USD Billion)
Table 28.3.1.5US — Market Size and Projections, 2020–2034, Revenue (USD Billion)
Table 28.3.1.6US Market Overview, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
Table 28.3.1.7US Market Overview, By Source, 2020–2034, Revenue (USD Billion)
Table 28.3.1.8US Market Overview, By Product Form, 2020–2034, Revenue (USD Billion)
Table 28.3.1.9US Market Overview, By Extraction Method, 2020–2034, Revenue (USD Billion)
Table 28.3.1.10US Market Overview, By Application, 2020–2034, Revenue (USD Billion)
Table 28.3.1.11US Market Overview, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
Table 28.3.1.12US Market Overview, By Purity Grade, 2020–2034, Revenue (USD Billion)
Table 28.3.1.13US Market Overview, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 28.3.1.14US Market Overview, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 28.3.1.15US Market Overview, By Legal Status, 2020–2034, Revenue (USD Billion)
Table 29.1Overview, 2020–2034
Table 29.2Size and Projections, 2020–2034, Revenue (USD Billion)
Table 29.2.1By Cannabinoid Type, 2020–2034
Table 29.2.2By Source, 2020–2034
Table 29.2.3By Product Form, 2020–2034
Table 29.2.4By Extraction Method, 2020–2034
Table 29.2.5By Application, 2020–2034
Table 29.2.6By Spectrum Profile, 2020–2034
Table 29.2.7By Purity Grade, 2020–2034
Table 29.2.8By Route of Administration, 2020–2034
Table 29.2.9By Distribution Channel, 2020–2034
Table 29.2.10By Legal Status, 2020–2034
Table 29.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 29.3.1.4Germany — Market Overview, 2020–2034, Revenue (USD Billion)
Table 29.3.1.5Germany — Market Size and Projections, 2020–2034, Revenue (USD Billion)
Table 29.3.1.6Germany Market Overview, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
Table 29.3.1.7Germany Market Overview, By Source, 2020–2034, Revenue (USD Billion)
Table 29.3.1.8Germany Market Overview, By Product Form, 2020–2034, Revenue (USD Billion)
Table 29.3.1.9Germany Market Overview, By Extraction Method, 2020–2034, Revenue (USD Billion)
Table 29.3.1.10Germany Market Overview, By Application, 2020–2034, Revenue (USD Billion)
Table 29.3.1.11Germany Market Overview, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
Table 29.3.1.12Germany Market Overview, By Purity Grade, 2020–2034, Revenue (USD Billion)
Table 29.3.1.13Germany Market Overview, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 29.3.1.14Germany Market Overview, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 29.3.1.15Germany Market Overview, By Legal Status, 2020–2034, Revenue (USD Billion)
Table 30.1Overview, 2020–2034
Table 30.2Size and Projections, 2020–2034, Revenue (USD Billion)
Table 30.2.1By Cannabinoid Type, 2020–2034
Table 30.2.2By Source, 2020–2034
Table 30.2.3By Product Form, 2020–2034
Table 30.2.4By Extraction Method, 2020–2034
Table 30.2.5By Application, 2020–2034
Table 30.2.6By Spectrum Profile, 2020–2034
Table 30.2.7By Purity Grade, 2020–2034
Table 30.2.8By Route of Administration, 2020–2034
Table 30.2.9By Distribution Channel, 2020–2034
Table 30.2.10By Legal Status, 2020–2034
Table 30.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 30.3.1.4India — Market Overview, 2020–2034, Revenue (USD Billion)
Table 30.3.1.5India — Market Size and Projections, 2020–2034, Revenue (USD Billion)
Table 30.3.1.6India Market Overview, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
Table 30.3.1.7India Market Overview, By Source, 2020–2034, Revenue (USD Billion)
Table 30.3.1.8India Market Overview, By Product Form, 2020–2034, Revenue (USD Billion)
Table 30.3.1.9India Market Overview, By Extraction Method, 2020–2034, Revenue (USD Billion)
Table 30.3.1.10India Market Overview, By Application, 2020–2034, Revenue (USD Billion)
Table 30.3.1.11India Market Overview, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
Table 30.3.1.12India Market Overview, By Purity Grade, 2020–2034, Revenue (USD Billion)
Table 30.3.1.13India Market Overview, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 30.3.1.14India Market Overview, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 30.3.1.15India Market Overview, By Legal Status, 2020–2034, Revenue (USD Billion)
Table 31.1Overview, 2020–2034
Table 31.2Size and Projections, 2020–2034, Revenue (USD Billion)
Table 31.2.1By Cannabinoid Type, 2020–2034
Table 31.2.2By Source, 2020–2034
Table 31.2.3By Product Form, 2020–2034
Table 31.2.4By Extraction Method, 2020–2034
Table 31.2.5By Application, 2020–2034
Table 31.2.6By Spectrum Profile, 2020–2034
Table 31.2.7By Purity Grade, 2020–2034
Table 31.2.8By Route of Administration, 2020–2034
Table 31.2.9By Distribution Channel, 2020–2034
Table 31.2.10By Legal Status, 2020–2034
Table 31.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 31.3.1.4Brazil — Market Overview, 2020–2034, Revenue (USD Billion)
Table 31.3.1.5Brazil — Market Size and Projections, 2020–2034, Revenue (USD Billion)
Table 31.3.1.6Brazil Market Overview, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
Table 31.3.1.7Brazil Market Overview, By Source, 2020–2034, Revenue (USD Billion)
Table 31.3.1.8Brazil Market Overview, By Product Form, 2020–2034, Revenue (USD Billion)
Table 31.3.1.9Brazil Market Overview, By Extraction Method, 2020–2034, Revenue (USD Billion)
Table 31.3.1.10Brazil Market Overview, By Application, 2020–2034, Revenue (USD Billion)
Table 31.3.1.11Brazil Market Overview, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
Table 31.3.1.12Brazil Market Overview, By Purity Grade, 2020–2034, Revenue (USD Billion)
Table 31.3.1.13Brazil Market Overview, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 31.3.1.14Brazil Market Overview, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 31.3.1.15Brazil Market Overview, By Legal Status, 2020–2034, Revenue (USD Billion)
Table 32.1Overview, 2020–2034
Table 32.2Size and Projections, 2020–2034, Revenue (USD Billion)
Table 32.2.1By Cannabinoid Type, 2020–2034
Table 32.2.2By Source, 2020–2034
Table 32.2.3By Product Form, 2020–2034
Table 32.2.4By Extraction Method, 2020–2034
Table 32.2.5By Application, 2020–2034
Table 32.2.6By Spectrum Profile, 2020–2034
Table 32.2.7By Purity Grade, 2020–2034
Table 32.2.8By Route of Administration, 2020–2034
Table 32.2.9By Distribution Channel, 2020–2034
Table 32.2.10By Legal Status, 2020–2034
Table 32.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 32.3.1.4GCC — Market Overview, 2020–2034, Revenue (USD Billion)
Table 32.3.1.5GCC — Market Size and Projections, 2020–2034, Revenue (USD Billion)
Table 32.3.1.6GCC Market Overview, By Cannabinoid Type, 2020–2034, Revenue (USD Billion)
Table 32.3.1.7GCC Market Overview, By Source, 2020–2034, Revenue (USD Billion)
Table 32.3.1.8GCC Market Overview, By Product Form, 2020–2034, Revenue (USD Billion)
Table 32.3.1.9GCC Market Overview, By Extraction Method, 2020–2034, Revenue (USD Billion)
Table 32.3.1.10GCC Market Overview, By Application, 2020–2034, Revenue (USD Billion)
Table 32.3.1.11GCC Market Overview, By Spectrum Profile, 2020–2034, Revenue (USD Billion)
Table 32.3.1.12GCC Market Overview, By Purity Grade, 2020–2034, Revenue (USD Billion)
Table 32.3.1.13GCC Market Overview, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 32.3.1.14GCC Market Overview, By Distribution Channel, 2020–2034, Revenue (USD Billion)
Table 32.3.1.15GCC Market Overview, By Legal Status, 2020–2034, Revenue (USD Billion)
Scope
Questions This Report Answers
6 questions01
What is the market size and growth rate, globally and by region?
02
How is the market segmented, and which segments lead?
03
Which regions and countries are covered, and how do they compare?
04
What are the key drivers, restraints, opportunities and challenges?
05
Who are the leading companies operating in this market?
06
What trends are expected to shape the market through the forecast period?
Questions
Frequently Asked Questions
01What is the Cannabinoids Market projected to reach?
USD 113.6 USD Billion by 2034, CAGR 13.59%
02What years does this report cover?
Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.
03Which regions are covered?
North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
04Which region accounted for the largest market share?
North America leads with 40% of global revenue through 2034.
05Which segment leads the market?
Cannabidiol (CBD) is the largest line by cannabinoid type, at 55% of revenue in 2025.
06Who are the key companies profiled?
Jazz Pharmaceuticals plc, Canopy Growth Corporation, Tilray Brands, Inc., Charlotte's Web Holdings, Inc., Aurora Cannabis Inc., Curaleaf Holdings, Inc., Cresco Labs Inc., Green Thumb Industries Inc., Trulieve Cannabis Corp., Mile High Labs, Inc., Medterra CBD, cbdMD, Inc., Isodiol International Inc., Elixinol Wellness Limited, Folium Biosciences, Cannexus Group, Cannextra, Red Mesa Science & Refining, Big Sky Scientific, Avient Biosciences, Organigram Global Inc., SNDL Inc., Bausch Health Companies Inc., Neuraxpharm Group, Botanix Pharmaceuticals Limited, Zynerba Pharmaceuticals, Inc., Aphria Inc., CV Sciences, Inc., Endoca, Cronos Group Inc.. Full profiles are part of the paid report.
07Can the segmentation be customized?
Yes. Custom data cuts by geography, segment, or competitor set are available on request.
425+
Dedicated research analysts
1,200+
Reports published
Why CDI
Why choose CDI
Data triangulated across primary and secondary sources
Complimentary analyst call included with every purchase
Custom data cuts and post-purchase support available
Need this report shaped around your question?
The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.
Most licences include 30–60 hours of customization at no extra cost. See what each licence includes
Additional Companies
Add competitors, suppliers or the peer set you benchmark against to the companies already covered.
Deeper Competitive View
Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.
Extra Segment Splits
Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.
Application Focus
Narrow the analysis to the specific use cases and end users your team actually sells into.
Different Time Frame
Move the base year, or widen the historical and forecast windows the study is built on.
Country-Level Detail
Go below region level into the individual countries that matter to you, rather than the standard geography split.
Explore
Related Reports
Chemicals & Materials
Cannabidiol Oil Cbd Oil
USD 30.55 Bn by 2034, CAGR 12.81%
Food & Beverages
Cannabis Market
USD 194.3 Bn by 2034, CAGR 12.18%
Pharmaceuticals & Biotech
Pneumoconiosis Market
USD 4.055 Bn by 2034, CAGR 6%
Pharmaceuticals & Biotech
Argan Oil Market
USD 1065.5 Mn by 2034, CAGR 11.31%
Pharmaceuticals & Biotech
Omega 3 Market
USD 14.12 Bn by 2034, CAGR 7.2%
Food & Beverages
Trehalose Market
USD 486.03 Mn by 2034, CAGR 8.69%